Seres Therapeutics MCRB
NASDAQ MCRB
$2.40 +0.09 (+3.90%)
As of: Oct 21, 2026 · 9:56 AM EDT

Seres Therapeutics (MCRB) Finished Goods (2023 - 2024)

Updated

Seres Therapeutics' Finished Goods was $484,000 in Q1 2024.

Analysis

Seres Therapeutics (MCRB) Finished Goods (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.97 Bn 1,099.55 Bn 19.71 Bn
2 Johnson & Johnson 614.97 Bn 533.50 Bn 17.26 Bn
3 AbbVie 505.56 Bn 478.67 Bn 12.70 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn
5 Novartis Ag 297.80 Bn 261.79 Bn 11.24 Bn
6 Astrazeneca 261.62 Bn 235.31 Bn 12.86 Bn
7 Amgen 235.78 Bn 191.18 Bn 7.24 Bn
8 Gilead Sciences 189.91 Bn 164.11 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Seres Therapeutics 23.29 Mn -115.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 484,000.00
Jun 30, 2023 43,000.00
API Access

Seres Therapeutics Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=MCRB&period=max&api_key=YOUR_API_KEY